Basal cell adenocarcinoma of the supraglottic larynx: treatment of recurrent disease with tamoxifen

At the age of 83, a woman presented with an extremely rare cancer, basal cell adenocarcinoma (BCAC) of the supraglottic larynx. Pathology revealed a stage IVA tumor, pathological stage T4N0M0. She was treated with surgery and did not receive any adjuvant chemotherapy or radiation therapy. At the age...

Descripción completa

Detalles Bibliográficos
Autores principales: Bailey, Christopher H., Donovan, Patrick J., Weiss, Glen J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications 2011
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3282460/
https://www.ncbi.nlm.nih.gov/pubmed/22355510
http://dx.doi.org/10.4081/rt.2011.e55
_version_ 1782224073672097792
author Bailey, Christopher H.
Donovan, Patrick J.
Weiss, Glen J.
author_facet Bailey, Christopher H.
Donovan, Patrick J.
Weiss, Glen J.
author_sort Bailey, Christopher H.
collection PubMed
description At the age of 83, a woman presented with an extremely rare cancer, basal cell adenocarcinoma (BCAC) of the supraglottic larynx. Pathology revealed a stage IVA tumor, pathological stage T4N0M0. She was treated with surgery and did not receive any adjuvant chemotherapy or radiation therapy. At the age of 93, during a routine examination, the patient was found to have palpable adenopathy and underwent a fine needle aspiration in June 2010. Pathology revealed similar histologic characteristics of her 2001 BCAC diagnosis, and further IHC stains revealed positive estrogen receptor staining.
format Online
Article
Text
id pubmed-3282460
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher PAGEPress Publications
record_format MEDLINE/PubMed
spelling pubmed-32824602012-02-21 Basal cell adenocarcinoma of the supraglottic larynx: treatment of recurrent disease with tamoxifen Bailey, Christopher H. Donovan, Patrick J. Weiss, Glen J. Rare Tumors Case Report At the age of 83, a woman presented with an extremely rare cancer, basal cell adenocarcinoma (BCAC) of the supraglottic larynx. Pathology revealed a stage IVA tumor, pathological stage T4N0M0. She was treated with surgery and did not receive any adjuvant chemotherapy or radiation therapy. At the age of 93, during a routine examination, the patient was found to have palpable adenopathy and underwent a fine needle aspiration in June 2010. Pathology revealed similar histologic characteristics of her 2001 BCAC diagnosis, and further IHC stains revealed positive estrogen receptor staining. PAGEPress Publications 2011-12-13 /pmc/articles/PMC3282460/ /pubmed/22355510 http://dx.doi.org/10.4081/rt.2011.e55 Text en ©Copyright C.H. Bailey et al., 2011 This work is licensed under a Creative Commons Attribution NonCommercial 3.0 License (CC BY-NC 3.0). Licensee PAGEPress, Italy
spellingShingle Case Report
Bailey, Christopher H.
Donovan, Patrick J.
Weiss, Glen J.
Basal cell adenocarcinoma of the supraglottic larynx: treatment of recurrent disease with tamoxifen
title Basal cell adenocarcinoma of the supraglottic larynx: treatment of recurrent disease with tamoxifen
title_full Basal cell adenocarcinoma of the supraglottic larynx: treatment of recurrent disease with tamoxifen
title_fullStr Basal cell adenocarcinoma of the supraglottic larynx: treatment of recurrent disease with tamoxifen
title_full_unstemmed Basal cell adenocarcinoma of the supraglottic larynx: treatment of recurrent disease with tamoxifen
title_short Basal cell adenocarcinoma of the supraglottic larynx: treatment of recurrent disease with tamoxifen
title_sort basal cell adenocarcinoma of the supraglottic larynx: treatment of recurrent disease with tamoxifen
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3282460/
https://www.ncbi.nlm.nih.gov/pubmed/22355510
http://dx.doi.org/10.4081/rt.2011.e55
work_keys_str_mv AT baileychristopherh basalcelladenocarcinomaofthesupraglotticlarynxtreatmentofrecurrentdiseasewithtamoxifen
AT donovanpatrickj basalcelladenocarcinomaofthesupraglotticlarynxtreatmentofrecurrentdiseasewithtamoxifen
AT weissglenj basalcelladenocarcinomaofthesupraglotticlarynxtreatmentofrecurrentdiseasewithtamoxifen

Ejemplares similares